🇺🇸▼
Extensive documentation exists regarding the profound physiological toll that extended exposure to microgravity exacts upon the human organism. These documented effects encompass significant muscle atrophy, a marked reduction in bone mineral density, and substantial alterations to the cardiovascular, endocrine, and nervous systems. However, emerging data from recent investigations indicate that female astronauts confront an additional, specific, and potentially life-threatening hazard: a significantly elevated risk of developing venous thromboembolism, commonly known as blood clots.
This discovery illuminates a critical and persistent gap within the existing body of scientific literature. To date, the overwhelming majority of studies concerning human health during spaceflight have been conducted exclusively with male participants. As the demographic diversity of the astronaut corps expands and the number of female astronauts continues to grow, it has become imperative to conduct rigorous, targeted research that addresses these potentially gender-specific physiological vulnerabilities.
This specific area of concern served as the primary motivation for a comprehensive new study designed to examine the intricate ways in which microgravity influences the coagulation cascade, with a distinct emphasis on female physiology. The research was executed by a collaborative team of scientists from Simon Fraser University (SFU) and the European Space Agency (ESA), with financial backing provided through a strategic grant from the Canadian Space Agency (CSA).
The experimental design involved eighteen healthy women who participated in a rigorous five-day dry immersion test. This specialized experimental protocol was utilized to assess the probability of developing potentially life-threatening blood clots within an environment that effectively simulates the microgravity conditions of space. The results generated by this study robustly support existing evidence suggesting that women are inherently more susceptible to venous thromboembolism. Furthermore, the investigation identified a state of hypercoagulability as a probable key mechanistic driver underlying this increased susceptibility.
The research leadership was directed by a team hailing from SFU's Aerospace Physiology Laboratory. This laboratory maintains a routine of collaboration with the Canadian Space Agency and various international space agencies to meticulously study the effects of space exploration on human physiology. The research consortium included experts from the Department of Biomedical Physiology and Kinesiology at SFU, the Medical University of Graz, Antwerp University Hospital, the University Medical Center Maribor, the European Astronaut Center Department (EACD), and the Mohammed Bin Rashid University of Medicine and Health Sciences. The detailed findings of this study were subsequently published in the peer-reviewed journal Acta Astronautica, establishing a new baseline for understanding these physiological responses.
On Earth, the formation of blood clots is frequently associated with the aging process, though these events can and do affect younger individuals as well. Due to the constant pull of Earth's gravity, blood tends to pool in the lower extremities, meaning clots generally form within the leg veins. When such clots form in these locations, they obstruct blood flow, which subsequently leads to significant pain and localized swelling. In the most severe instances, these clots can dislodge and travel through the bloodstream to the lungs, causing a catastrophic pulmonary embolism, heart attack, or stroke. Fortunately, when clots form in the legs, the patient typically has a crucial window of time to seek medical intervention. Physicians can often mechanically remove the clot, or the body's natural fibrinolytic system may gradually break it down.
However, the physiological rules change drastically in microgravity. In the absence of gravity, blood redistributes, pooling in the head and sometimes in the feet, creating a specific hemodynamic environment where the likelihood of clot formation is significantly heightened.
As articulated by Dr. Andrew Blaber in an SFU press release, the specific anatomical location of clots in space creates a uniquely dangerous scenario:
We've found that in space, blood clots are more likely to form in the jugular vein. From there, it doesn't have to travel far to reach [the] lungs or heart, and trigger a serious medical event. Space is not a place where you want these things to happen. Now that they know it can happen, they're looking at it more frequently as part of the standard measures.
The initial signals that female astronauts might be at a disproportionately high risk of clotting emerged in 2020. During that year, a female astronaut stationed aboard the International Space Station (ISS) developed an unexpected and alarming clot in her jugular vein. For the current investigation, the team examined real-time clotting responses in eighteen healthy women over a continuous five-day period. They utilized a dry immersion tank, a sophisticated apparatus consisting of a water bath sealed with a waterproof membrane. This device kept the volunteers' skin dry while they floated, effectively simulating the somatic sensation of weightlessness without the inherent risks of actual orbital flight.
The research team then analyzed the participants using rotational thromboelastometry, commonly referred to as ROTEM. This advanced diagnostic technology measures the rate at which blood clots form and how they progress, providing a dynamic view of the coagulation process. This rapid blood-testing methodology assesses coagulation function in real-time and identifies the specific causes of bleeding disorders. The researchers also analyzed the volunteers' blood for the presence of specific menstrual hormones. They discovered that these hormonal fluctuations had no significant effect on blood coagulation within this specific microgravity context.
The key findings of the study indicate a complex and counterintuitive process: the latency period—the time it takes for blood clots to initiate formation in microgravity—is actually longer. However, once the coagulation process begins, the clots form much more rapidly. Additionally, once formed, the clots demonstrated greater mechanical strength and stability than what is typically observed with patients on Earth.
Said Blaber regarding these findings:
We know that on Earth, clotting in men and women can vary with age, but we have little information on whether these will be different when in space. In this microgravity environment, we found the female participants took longer for their blood to start clotting. But once that clotting began, it formed faster and was more stable, making it harder to break down.
While the study findings were not immediately alarming after just five days of immersion, they raise serious and pressing concerns for astronaut crews that will be operating far from any medical facility or emergency care. The results indicate that further research is urgently needed to assess potential risks to crews on long-duration missions. This includes crews operating on the Moon as part of NASA's Artemis Program and on future interplanetary missions to Mars. On these arduous voyages, astronauts will spend months in transit, entirely isolated from immediate assistance. Blaber and his team are now analyzing and comparing their results to dry immersion studies involving male volunteers to determine if there are statistically significant gender differences in these physiological responses.
These studies will be instrumental in informing future medical monitoring and treatment procedures required for longer missions to deep space. Understanding these mechanisms is absolutely critical for the safety and survival of future explorers. In the interim, space agencies are already implementing precautionary measures. Astronauts aboard the ISS are routinely undergoing jugular vein ultrasounds. This is the same diagnostic imaging technique that accidentally identified the female astronaut's clot in 2020. By increasing the frequency of these non-invasive screenings, agencies are ensuring that potential clots are detected at the earliest possible stage. This proactive approach is essential as humanity prepares to venture further into the cosmos, a domain where medical resources are extremely limited and the consequences of a blocked vessel could be catastrophic.
The transition from short-duration missions in low Earth orbit to long-duration voyages on the Moon and beyond necessitates a deeper, more nuanced understanding of human physiology. The findings from this study provide a crucial piece of that complex puzzle. They confirm that women face distinct physiological challenges in space, particularly regarding blood flow dynamics and clotting stability. As the space industry diversifies and more women join the ranks of professional astronauts, the data generated from these studies will become increasingly vital. It ensures that medical protocols are not based on assumptions derived solely from male physiology, but on comprehensive, evidence-based data that reflects the reality of the diverse crews who will explore the solar system. The safety of these crews depends entirely on the precision of this research and the willingness of the scientific community to adapt medical standards to the unique, unforgiving environment of space.